Medicare Enrolled

Dr. Robert Yeaman, O.D.

Optometrist · Granbury, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4000 E US HIGHWAY 377, Granbury, TX 76049
8175737153
In practice since 2005 (20 years)
NPI: 1134122260 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yeaman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yeaman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yeaman

Dr. Robert Yeaman is an optometrist in Granbury, TX, with 20 years in practice. Based on federal Medicare data, Dr. Yeaman performed 500 Medicare services across 449 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yeaman received a total of $2,027 from 20 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yeaman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 23% volume in TX$ $2,027 industry payments

Medicare Practice Summary

Medicare Utilization ↗
500
Medicare services
Top 23% in TX for optometrist
449
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~25 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Comprehensive eye exam, established patient208$73$130
Office visit, established patient (20-29 min)93$58$90
Retinal imaging (OCT scan)47$27$45
Comprehensive eye exam, new patient39$68$150
Optic nerve imaging (OCT scan)39$22$45
Visual field test, extended34$35$85
Office visit, established patient (30-39 min)27$91$130
Photography of content of eyes13$17$25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,027
Total received (2018-2024)
Avg $290/year across 7 years
Top 26% in TX for optometrist
20
Companies
74
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,027 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$251
2023
$262
2022
$478
2021
$385
2020
$299
2019
$126
2018
$227

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb, a division of Bausch Health US, LLC
$442
Bausch & Lomb Americas Inc.
$381
CooperVision Inc.
$361
Glaukos Corporation
$111
Optos, Inc.
$105
GENZYME CORPORATION
$100
ABBVIE INC.
$95
Alcon Vision LLC
$81
Tarsus Pharmaceuticals, Inc.
$58
Sun Pharmaceutical Industries Inc.
$56
Alcon Laboratories Inc
$50
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Carl Zeiss Meditec USA, Inc.
$24
Kala Pharmaceuticals, Inc.
$23
Novartis Pharmaceuticals Corporation
$18
Oyster Point Pharma, Inc.
$18
AbbVie Inc.
$16
BIOTISSUE HOLDINGS INC.
$16
BIOTISSUE HOLDINGS, INC.
$13
MacuLogix, Inc.
$13
Top 3 companies account for 58.4% of total payments
Associated products mentioned in payments ›
ALDEN SCLERAL ZENLENS · AdaptDx · BIOTRUE · BTOD · CIRRUS HD-OCT · Cequa · Clariti Contact Lens · DAILIES · DOCTORS ALLERGY FORMULA · INFUSE · INVELTYS · LUMIZYME · MyDay Contact Lens · OCT OPHTHALMOSCOPE · PROKERA · Precision 1 · TOTAL30 · TYRVAYA · ULTRA · VUITY · XDEMVY · XIIDRA · iStent Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $405 per 100 Medicare services performed
Looking for a optometrist in Granbury?
Compare optometrists in the Granbury area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
105
Per 100K population
163.6
County median income
$86,802
Nearest hospital
LAKE GRANBURY MEDICAL CENTER
6.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yeaman is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yeaman experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Yeaman performed 208 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yeaman receive payments from pharmaceutical companies?
Yes. Dr. Yeaman received a total of $2,027 from 20 companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yeaman's costs compare to other optometrists in Granbury?
Dr. Yeaman's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yeaman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →